<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2020.00596</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Duck Tembusu Virus Utilizes miR-221-3p Expression to Facilitate Viral Replication <italic>via</italic> Targeting of Suppressor of Cytokine Signaling 5</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Cui</surname> <given-names>Min</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Shuling</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Shaqiu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/776684/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cheng</surname> <given-names>Anchun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/336831/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pan</surname> <given-names>Yuhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Juan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname> <given-names>Zhiqiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Xingcui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Mingshu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/663466/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname> <given-names>Dekang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/336792/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Shun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Mafeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/114098/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Xinxin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/398170/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Yin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Qiao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Yunya</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Ling</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname> <given-names>Yanling</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yin</surname> <given-names>Zhongqiong</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/530899/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jing</surname> <given-names>Bo</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rehman</surname> <given-names>Mujeeb Ur</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/526962/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tian</surname> <given-names>Bin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/477633/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pan</surname> <given-names>Leichang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/782061/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jia</surname> <given-names>Renyong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/539854/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Avian Diseases Research Center, College of Veterinary Medicine, Sichuan Agricultural University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute of Preventive Veterinary Medicine, Sichuan Agricultural University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine, Sichuan Agricultural University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Akio Adachi, Kansai Medical University, Japan</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Zhixun Xie, Guangxi Veterinary Research Institute, China; Qiyun Zhu, Lanzhou Veterinary Research Institute (CAAS), China; Guijun Wang, Anhui Agricultural University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Anchun Cheng, <email>chenganchun@vip.163.com</email></corresp>
<corresp id="c002">Renyong Jia, <email>jiary@sicau.edu.cn</email></corresp>
<fn fn-type="other" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Virology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>04</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>596</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>01</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>03</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2020 Cui, Chen, Zhang, Cheng, Pan, Huang, Hu, Zhang, Wang, Zhu, Chen, Liu, Zhao, Wu, Yang, Liu, Zhang, Yu, Yin, Jing, Rehman, Tian, Pan and Jia.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Cui, Chen, Zhang, Cheng, Pan, Huang, Hu, Zhang, Wang, Zhu, Chen, Liu, Zhao, Wu, Yang, Liu, Zhang, Yu, Yin, Jing, Rehman, Tian, Pan and Jia</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Duck Tembusu virus (DTMUV), a member of <italic>Flaviviridae</italic> family, causes acute egg-drop syndrome in ducks. MicroRNAs (miRNAs) have been found to be involved in various biological processes, including tumor genesis, viral infection, and immune response. However, the functional effect of miRNAs on DTMUV replication remains largely unclear. This study aimed to elucidate the role of host microRNA-221-3p (miR&#x2212;221-3p) in regulating DTMUV replication. Here, we indicated that the expression of miR&#x2212;221-3p was significantly upregulated in duck embryo fibroblasts (DEFs) during DTMUV infection. Transfection of miR-221-3p mimic significantly reduced interferon (IFN) &#x03B2; production, whereas transfection of miR-221-3p inhibitor conversely significantly increased the expression of IFN-&#x03B2; in DTMUV-infected DEF. Moreover, we found that viral RNA copies, viral E protein expression level, and virus titer, which represent the replication and proliferation of virus, were all enhanced when transfecting the miR-221-3p mimic into DEF; reverse results were also observed by transfecting the miR-221-3p inhibitor. We also found that the expression of suppressor of cytokine signaling 5 (SOCS5) was downregulated in DEF infected with DTMUV. Besides, we further proved that SOCS5 is a target of miR-221-3p and that miR-221-3p could negatively modulate SOCS5 expression at both mRNA and protein levels. Finally, our results showed that overexpression of SOCS5 inhibited DTMUV replication and knockdown of SOCS5 enhanced DTMUV replication. Thus, our findings reveal a novel host evasion mechanism adopted by DTMUV <italic>via</italic> miR-221-3p, which may hew out novel strategies for designing miRNA-based vaccines and therapies.</p>
</abstract>
<kwd-group>
<kwd>duck Tembusu virus</kwd>
<kwd>miR-221-3p</kwd>
<kwd>interferon beta</kwd>
<kwd>suppressor of cytokine signaling 5</kwd>
<kwd>immune response</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="81"/>
<page-count count="13"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Duck Tembusu virus (DTMUV) belongs to the genus <italic>Flavivirus</italic> of the <italic>Flaviviridae</italic> family. DTMUV was first detected in China in 2010, then quickly spread to most regions of China, causing serious economic losses in the duck industry (<xref ref-type="bibr" rid="B24">Jingliang et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Pixi et al., 2011</xref>; <xref ref-type="bibr" rid="B80">Zhenzhen et al., 2011</xref>). In recent years, the infection of TMUV has also emerged in chickens, geese, and sparrows (<xref ref-type="bibr" rid="B62">Tao et al., 2012</xref>; <xref ref-type="bibr" rid="B60">Tang et al., 2013a</xref>; <xref ref-type="bibr" rid="B54">Shilong et al., 2014</xref>; <xref ref-type="bibr" rid="B63">Ti et al., 2015</xref>). More importantly, the potential case of human infection by TMUV was also reported in recent research, suggesting that the virus may pose a threat to public health (<xref ref-type="bibr" rid="B61">Tang et al., 2013b</xref>).</p>
<p>miRNAs, a highly conversed non-coding small RNAs of about 22nt in length, play key regulator roles in gene expression through transcription repression or mRNA destabilization <italic>via</italic> suppression of gene expression by binding to the complementary sequences in 3-untranslated region (UTR) of target mRNAs (<xref ref-type="bibr" rid="B3">Bartel, 2004</xref>; <xref ref-type="bibr" rid="B34">Lin and Hannon, 2004</xref>; <xref ref-type="bibr" rid="B67">Victor, 2004</xref>; <xref ref-type="bibr" rid="B16">Fabbri et al., 2007</xref>). It is now well documented that there is a correlation between miRNAs expression and viral infection (<xref ref-type="bibr" rid="B41">Ojha et al., 2016</xref>; <xref ref-type="bibr" rid="B64">Trobaugh and Klimstra, 2017</xref>; <xref ref-type="bibr" rid="B20">Hussein et al., 2019</xref>; <xref ref-type="bibr" rid="B22">Islam et al., 2019</xref>; <xref ref-type="bibr" rid="B48">Sartorius et al., 2019</xref>). In particular, recent studies further suggested that the expression profiles of host miRNAs were changed or viral miRNAs were generated during viral infection (<xref ref-type="bibr" rid="B55">Skalsky and Cullen, 2006</xref>; <xref ref-type="bibr" rid="B28">Kincaid and Sullivan, 2012</xref>; <xref ref-type="bibr" rid="B5">Castro et al., 2019</xref>). In turn, these host and viral miRNAs can also affect the process of virus infection <italic>via</italic> targeting viral genome or host genes (<xref ref-type="bibr" rid="B59">Sullivan and Ganem, 2005</xref>; <xref ref-type="bibr" rid="B50">Scaria et al., 2006</xref>; <xref ref-type="bibr" rid="B41">Ojha et al., 2016</xref>). For instance, a direct role of miR-34b enhancing avian leucosis virus (ALV-J) replication was revealed by repressing melanoma differentiation-associated gene 5 (MDA5) expression (<xref ref-type="bibr" rid="B33">Li et al., 2017</xref>). Further, increasing studies have also proved that miRNAs could also regulate flaviviral infection. As an illustration, the members of miR-34a family inhibited the replication of Dengue virus (DENV), West Nile virus (WNV), and Japanese encephalitis virus (JEV) <italic>via</italic> repression of Wnt signaling and activation of interferon (IFN) response (<xref ref-type="bibr" rid="B57">Smith et al., 2017</xref>). miR-281, let-7c, miR-484, and miR-744 modulated DENV-2 replication through targeting the DENV genome (<xref ref-type="bibr" rid="B81">Zhou et al., 2014</xref>; <xref ref-type="bibr" rid="B15">Escalera-Cueto et al., 2015</xref>; <xref ref-type="bibr" rid="B4">Castrillon-Betancur and Urcuqui-Inchima, 2017</xref>). miR-532-5p restricted WNV infection by targeting two host genes, including SEC14 and spectrin domain containing 1 (SESTD1) and transforming growth factor-b-activated kinase 1/MAP3K7 binding protein 3 (TAB3) (<xref ref-type="bibr" rid="B56">Slonchak et al., 2015</xref>). Taken together, the effects of miRNAs on these flaviviral infections (including JEV, DENV, and WNV) have already been extensively studied. However, the regulatory role of host miRNAs during the progress of DTMUV infection remains unknown.</p>
<p>Furthermore, there are growing evidences that showed that miRNAs regulate the infection process of various viruses by regulating the immune response of host organisms (<xref ref-type="bibr" rid="B72">Xiao and Rajewsky, 2009</xref>; <xref ref-type="bibr" rid="B37">Lu and Liston, 2010</xref>; <xref ref-type="bibr" rid="B66">Urcuqui-Inchima et al., 2017</xref>; <xref ref-type="bibr" rid="B2">Annie and Selena, 2018</xref>; <xref ref-type="bibr" rid="B38">Momen-Heravi and Bala, 2018</xref>). Several cellular miRNAs were utilized by viruses to evade host immunity. For example, miR-132 was upregulated in three herpesvirus infection, including herpes simplex virus type 1 (HSV-1), Kaposi&#x2019;s sarcoma-associated herpesvirus (KSHV), and human cytomegalovirus (HCMV). The miR-132 negatively modulated IFN-stimulated genes (ISGs) production through suppressing the expression of the p300 transcriptional coactivator, which results in immune evasion of the three herpesvirus infection (<xref ref-type="bibr" rid="B31">Lagos et al., 2010</xref>). It is also reported that HSV-1 exploited miR-23a to avoid host immune response <italic>via</italic> targeting IFN regulatory factor 1 (IRF1), finally facilitating HSV-1 replication (<xref ref-type="bibr" rid="B23">Jing et al., 2014</xref>). During JEV infection, miR-301a inhibited antiviral IFN response and promoted immune evasion by targeting IRF-1 and cytokine signaling 5 (SOCS5) (<xref ref-type="bibr" rid="B19">Hazra et al., 2017</xref>). Similarly, miR-146a has been found to be involved in the immune evasion of DENV and JEV infection. It was confirmed that miR-146a prevented IFN response <italic>via</italic> targeting tumor necrosis factor receptor-associated protein 6 (TRAF6), thus promoting the infection of DENV and JEV (<xref ref-type="bibr" rid="B71">Wu et al., 2013</xref>; <xref ref-type="bibr" rid="B53">Sharma et al., 2015</xref>). Therefore, we aimed to uncover the complex relationships between miRNAs and host immune response during DTMUV infection.</p>
<p>In the previous study, we have identified the miRNA profiles in DTMUV-infected and uninfected duck embryo fibroblast (DEF), and we found that 48 cellular miRNAs were dysregulated, including miR-221-3p (<xref ref-type="bibr" rid="B9">Cui et al., 2018</xref>). Currently, miR-221-3p has been shown to be overexpressed in many tumor cells and has become a unique marker of the tumor (<xref ref-type="bibr" rid="B73">Xing Xiang et al., 2010</xref>; <xref ref-type="bibr" rid="B8">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B26">Kawaguchi et al., 2013</xref>; <xref ref-type="bibr" rid="B74">Xing Xing et al., 2014</xref>). Recent research studies have shown that miR-221 is also associated with viral infection (<xref ref-type="bibr" rid="B75">Xu et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Du et al., 2018</xref>). For instance, miR-221 was found to repress HCV replication by targeting suppressor of cytokine signaling 1 (SOCS1) and suppressor of cytokine signaling 3 (SOCS3) (<xref ref-type="bibr" rid="B75">Xu et al., 2014</xref>). A recent study demonstrated that miR-221 negatively regulated innate immune response and promoted VSV and HSV-1 replication (<xref ref-type="bibr" rid="B12">Du et al., 2018</xref>). However, whether the upregulated miR-221-3p in DTMUV-infected DEF will affect the replication of DTMUV has not been reported until now.</p>
<p>In this study, we chose a significantly upregulated miR-221-3p to investigate its effect on IFN production and DTMUV replication. Our results showed that miR-221-3p mimic transfection inhibited the production of IFN-&#x03B2;, while it increased DTMUV E protein expression, the viral RNA copies, and virus titer. Then we further proved that miR-221-3p could downregulate SOCS5 expression <italic>via</italic> binding the 3&#x2032;-UTR of SOCS5. We also found that DTMUV replication was enhanced through knockdown of SOCS5. Taken together, our results showed that miR-221-3p facilitated DTMUV replication <italic>via</italic> the downregulation of SOCS5. Thus, our findings unveil a novel host evasion mechanism adopted by DTMUV through miR-221-3p, which may open up a new avenue for therapeutic intervention.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Ethics Approval and Consent to Participate</title>
<p>The usage of duck embryos and ducks in this study was approved by the Animal Ethics Committee of Sichuan Agricultural University (approval no. XF2016-17) and followed the National Institutes of Health guidelines for the performance of animal experiments.</p>
</sec>
<sec id="S2.SS2">
<title>Cell and Virus</title>
<p>DEFs were prepared from 9-day-old duck embryos and cultured in Dulbecco&#x2019;s modified Eagle medium (DMEM) (12800017, Gibco, United States) supplemented with 10% fetal bovine serum (FBS) (16010159, Gibco, United States) at 37&#x00B0;C in 5% CO<sub>2</sub> incubator. The DTMUV CQW strain (GenBank: KM233707.1) was obtained from the Key Laboratory of Animal Disease and Human Health of Sichuan Province. For viral infection, monolayer DEF cells were infected with the DTMUV CQW strain at a multiplicity of infection (MOI) of 1 in DMEM supplemented with 2% FBS.</p>
</sec>
<sec id="S2.SS3">
<title>miRNA Target Prediction</title>
<p>The potential miRNA target genes were predicted by RNAhybrid and miRanda at default settings (<xref ref-type="bibr" rid="B30">Krek et al., 2005</xref>; <xref ref-type="bibr" rid="B44">Rajewsky, 2006</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>Transfection of miRNA Mimic and Inhibitor</title>
<p>miR-221-3p mimic, mimic negative control (mimic-NC), miR-221-3p inhibitor, and inhibitor negative control (inhibitor-NC) were purchased from RiboBio (Guangzhou, China). DEF cells were seeded into 6-well or 12-well plates and cultured in DMEM with 10% FBS at 37&#x00B0;C. When the DEF cells were grown to 70&#x2013;80% confluence, the miRNA mimic (100 nmol), mimic-NC (100 nmol), inhibitor (200 nmol), and inhibitor-NC (200 nmol) were transfected into the cells using Lipofectamine 3000 (Invitrogen, United States) according to the manufacturer&#x2019;s protocol. After 24 h of transfection, the DEF cells were infected with the DTMUV CQW strain. Then, the cells were collected for future analysis at 36 or 72 h after infection.</p>
</sec>
<sec id="S2.SS5">
<title>Knockdown and Overexpression of Suppressor of Cytokine Signaling 5</title>
<p>Three shRNAs against SOCS5 were synthesized in Shanghai GenePharma Co, Ltd.; and pcDNA3.1(+)-SOCS5 plasmid was constructed. DEF cells were seed into 6-well plates and cultured at 37&#x00B0;C in 5% CO<sub>2</sub> incubator. When the DEF cells were grown to 70&#x2013;80% confluence, SOCS5 shRNAs, pcDNA3.1(+)-SOCS5, and their respective controls were transfected into DEF cells using Lipofectamine 3000 according to the manufacturer&#x2019;s protocol. After 24 h of transfection, the DEF cells were infected with DTMUV, and the cells were collected for future analysis at the indicated time.</p>
</sec>
<sec id="S2.SS6">
<title>RNA Isolation and Quantitative Real-Time PCR</title>
<p>Total RNA from treated DEF was isolated using RNAiso plus reagent (9109, TaKaRa, Japan) according to the manufacturer&#x2019;s instruction. The concentration of total RNA was determined by NanoDrop 2000 (Thermo Fisher, United States). The primers used in qRT-PCR are listed in <xref ref-type="table" rid="T1">Table 1</xref>. For miRNA quantification, cDNA was prepared with stem-loop structured reverse primers using PrimeScript<sup>TM</sup> RT Master Mix (RR036A, TaKaRa, Japan). For mRNA quantification, 1 &#x03BC;g of total RNA was reverse transcribed with random primers using PrimeScript<sup>TM</sup> RT Master Mix (RR036A, TaKaRa, Japan). Then the expression levels of miRNAs and mRNA were quantified using a real-time PCR Detection System (Bio-Rad, United States). U6 and &#x03B2;-actin were used as the internal control for miRNAs and mRNA, respectively. All samples were conducted in triplicate on the same plate. The relative gene expression was calculated by the 2<sup>&#x2013;&#x0394;&#x0394;CT</sup> method.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>The primers used in the qRT-PCR experiments.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Primer name</td>
<td valign="top" align="left">Sequence (5&#x2032;&#x2013;3&#x2032;)</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">miR-221-3p RT-primer</td>
<td valign="top" align="left">GTCGTATCCAGTGCAGGGTCCGAGG TATTCGCACTGGATACGACGAAACCCA</td>
</tr>
<tr>
<td valign="top" align="left">miR-221-3p F</td>
<td valign="top" align="left">CGTCAAGCTACATTGTCTGCTG</td>
</tr>
<tr>
<td valign="top" align="left">miR-221-3p R</td>
<td valign="top" align="left">CAGTGCAGGGTCCGAGGTAT</td>
</tr>
<tr>
<td valign="top" align="left">U6 F</td>
<td valign="top" align="left">CTCGCTTCGGCAGCACA</td>
</tr>
<tr>
<td valign="top" align="left">U6 R</td>
<td valign="top" align="left">GCGTGTCATCCTTGCGC</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x03B1; F</td>
<td valign="top" align="left">TCCTCCAACACCTCTTCGAC</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x03B1; R</td>
<td valign="top" align="left">GGGCTGTAGGTGTGGTTCTG</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x03B2; F</td>
<td valign="top" align="left">TCTACAGAGCCTTGCCTGCAT</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x03B2; R</td>
<td valign="top" align="left">TGTCGGTGTCCAAAAGGATGT</td>
</tr>
<tr>
<td valign="top" align="left">SOCS5 F</td>
<td valign="top" align="left">TTCCTGCTCTACCAAAACCC</td>
</tr>
<tr>
<td valign="top" align="left">SOCS5 R</td>
<td valign="top" align="left">CTACTGTCCTGTTCGATACTGC</td>
</tr>
<tr>
<td valign="top" align="left">DTMUV-E F</td>
<td valign="top" align="left">AATGGCTGTGGCTTGTTTGG</td>
</tr>
<tr>
<td valign="top" align="left">DTMUV-E R</td>
<td valign="top" align="left">GGGCGTTATCACGAATCTA</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2;-Actin F</td>
<td valign="top" align="left">CCGGGCATCGCTGACA</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2;-Actin R</td>
<td valign="top" align="left">GGATTCATCATACTCCTGCTTGCT</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>IFN, interferon; SOCS5, suppressor of cytokine signaling 5; DTMUV, duck Tembusu virus.</italic></attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S2.SS7">
<title>Western Blot</title>
<p>The transfected cells were washed gently using ice-cold phosphate-buffered saline (PBS) for three times and then lysed with radioimmunoprecipitation assay (RIPA) buffer (89900, Thermo Fisher, United States) containing 1% phenylmethylsulfonyl fluoride (PMSF) (36978, Thermo Fisher, United States) for 30 min on ice. After being boiled with 5&#x00D7; sodium dodecyl sulfate (SDS) loading buffer for 10 min, the lysates were separated by 12% SDS&#x2013;polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes (ISEQ00010, Millipore, United States). The membranes were blocked with 5% skim milk for 2 h at room temperature and then incubated with the rabbit anti-SOCS5 polyclonal antibody (GTX104722, GeneTex, United States) at 1:1,000 dilution or the mouse anti-E monoclonal antibody (prepared in our lab) at 1:2,000 dilution or anti-&#x03B2;-actin mouse monoclonal antibody (60008, Proteintech, China) at 1:2,000 dilution at 4&#x00B0;C overnight. Thereafter, the horseradish peroxidase (HRP)-conjugated goat anti-rabbit (A0208, Beyotime, China) and goat anti-mouse IgG (A0216, Beyotime, China) were used as the secondary antibody. Finally, the protein signals were detected using the enhanced chemiluminescence (ECL) reagent (1705060, Bio-Rad, United States).</p>
</sec>
<sec id="S2.SS8">
<title>Dual-Luciferase Reporter Assay</title>
<p>The pmirGLO plasmid was observed in our laboratory. The wild-type 3&#x2032;-UTR of SOCS5 was amplified by ordinary PCR, and the mutant SOCS5 3&#x2032;-UTR was amplified <italic>via</italic> the overlap extension PCR method. The primers used are shown in <xref ref-type="table" rid="T2">Table 2</xref>. The PCR products were cloned into the pmirGLO plasmid between the <italic>Sac</italic>I and <italic>Xba</italic>I restriction enzyme sites. The recombinant plasmids were identified by restriction enzyme digestion and DNA sequencing. For the dual-luciferase reporter assay, pmirGLO-SOCS5-Wt or pmirGLO-SOCS5-Mut were co-transfected with miR-221-3p mimic or inhibitor into DEF using Lipofectamine 3000. Forty-eight hours after transfection, the firefly luciferase and Renilla luciferase activities were detected using Dual-Glo Luciferase Assay System (E2920, Promega, United States) according to the manufacturer&#x2019;s protocol. The relative reporter activity was normalized by Renilla luciferase activity.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>The primers used in the dual-luciferase reporter assay.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Primer name</td>
<td valign="top" align="left">Sequence (5&#x2032;&#x2013;3&#x2032;)</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">SOCS5-Wt F</td>
<td valign="top" align="left">TCCGAGCTCCTTCTCTATGGCAGTGACCT</td>
</tr>
<tr>
<td valign="top" align="left">SOCS5-Wt R</td>
<td valign="top" align="left">CTAGTCTAGATAAAATGCTCTATHCCTGCG</td>
</tr>
<tr>
<td valign="top" align="left">SOCS5-Mt F</td>
<td valign="top" align="left">CACGTAACCGACGTCAGTTAACTGAGTTTTAATAG</td>
</tr>
<tr>
<td valign="top" align="left">SOCS5-Mt R</td>
<td valign="top" align="left">GACGTCGGTTACGTGAATATATAAAAAC</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="S2.SS9">
<title>Virus Titer</title>
<p>DEF cells were seeded into 96-well plates and cultured overnight. The virus was serially diluted with DMEM from 10<sup>1</sup>- to 10<sup>8</sup>-fold containing 2% FBS, and the diluted virus with 100 &#x03BC;l was added to corresponding wells. Then the culture plates were incubated at 37&#x00B0;C in 5% CO<sub>2</sub> incubator for 3&#x2013;5 days until the appearance of cytopathic effects (CPEs). The CPE was observed under the microscope, and the TCID<sub>50</sub> values were calculated using the Reed and Muench method (<xref ref-type="bibr" rid="B46">Reed and Muench, 1938</xref>).</p>
</sec>
<sec id="S2.SS10">
<title>Statistical Analysis</title>
<p>Data are provided as means &#x00B1; SEM, and <italic>n</italic> represents the number of independent experiments. All data were tested for significance using the unpaired Student&#x2019;s <italic>t</italic>-test. Data were analyzed by Excel 2019 or GraphPad Prism Software 6.0, United States. <italic>P</italic>-value &#x2264;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title>Duck Tembusu Virus Infection Upregulated miR-221-3p Expression</title>
<p>Previously, we have described that the expression of miR-221-3p was changed in DEF in response to DTMUV infection (<xref ref-type="bibr" rid="B9">Cui et al., 2018</xref>). Here, we investigated the expression profiles of miR-221-3p in DTMUV-infected DEF cells. As shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>, the expression of miR-221-3p was significantly increased at 24, 36, and 48 h post infection in a time-dependent manner, when compared with that of control groups. Then, we further investigated whether DTMUV infection affected the miR-221-3p expression in ducks. The spleen tissues of uninfected and DTMUV-infected ducklings were collected at 3 days post infection in our laboratory. As shown in <xref ref-type="fig" rid="F1">Figure 1B</xref>, the expression of miR-221-3p was increased about 20-folds than that of the control group. Taken together, these results indicated that the expression of miR-221-3p was upregulated upon DTMUV infection.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Duck Tembusu virus (DTMUV) infection upregulated miR-221-3p expression <italic>in vitro</italic> and <italic>in vivo</italic>. <bold>(A)</bold> The duck embryo fibroblast (DEF) cells were plated in 6-well plates and infected with the DTMUV at multiplicity of infection (MOI) = 1. Then, the cells were collected at the indicated times. RNAiso reagent was used to extract total RNA, and qRT-PCR analysis was used to determine miR-221-3p expression level. <bold>(B)</bold> The spleen tissue from DTMUV-infected ducklings and control spleen tissue were conserved in our laboratory. The miR-221-3p expression level from these tissues was detected by qRT-PCR analysis. U6 was used as an internal reference. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;<italic>P</italic> &#x003C; 0.05 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g001.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>Overexpression miR-221-3p Inhibited Interferon Production</title>
<p>To date, many studies have demonstrated that miRNAs could regulate IFN production (<xref ref-type="bibr" rid="B70">Witwer et al., 2010</xref>; <xref ref-type="bibr" rid="B17">Forster et al., 2015</xref>). To explore the effect of miR-221-3p on type I IFN expression in DEF upon DTMUV infection, we transfected DEF with miR-221-3p mimic or inhibitor to measure the expression of type I IFN. Firstly, the miR-221-3p expression levels were detected in miR-221-3p mimic and inhibitor transfected DEF by qRT-PCR. As shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>, in mimic transfected cells, the expression of miR-221-3p was significantly increased about 70-folds than that of the mimic-NC transfected cells. We also confirmed that the expression of miR-221-3p was decreased in miR-221-3p inhibitor transfected cells compared with the inhibitor-NC transfected cells. Subsequently, we found that IFN-&#x03B1; expression was not affected in mimic and inhibitor transfected cells compared with their respective controls (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The expression of IFN-&#x03B2; was decreased in miR-221-3p mimic transfected cells, compared with the mimic-NC transfected cells. In contrast, the expression of IFN-&#x03B2; was increased in miR-221-3p inhibitor transfected cells, when compared with the inhibitor-NC transfected cells (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Therefore, overexpression miR-221-3p inhibited IFN-&#x03B2; production and inhibition of miR-221-3p promoted IFN-&#x03B2; production. These data indicated that miR-221-3p could negatively regulate the production of IFN-&#x03B2;.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>The effect of miR-221-3p on interferon (IFN) production. Duck embryo fibroblast (DEF) cells were transfected with 100 nM of mimic, 100 nM of mimic-NC, 200 nM of inhibitor, and 200 nM of inhibitor-NC for 24 h and then infected with duck Tembusu virus (DTMUV) at a multiplicity of infection (MOI) of 1. After 36 h of infection, total RNA was extracted using RNAiso reagent. The miR-221-3p <bold>(A)</bold>, IFN-&#x03B1; <bold>(B)</bold>, and IFN-&#x03B2; <bold>(C)</bold> expression levels were detected by qRT-PCR. U6 was used to normalize miRNA, and &#x03B2;-actin was used to normalize IFN mRNA. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;<italic>P</italic> &#x003C; 0.05 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Overexpression miR-221-3p Promoted Duck Tembusu Virus Replication</title>
<p>A growing body of evidence has demonstrated that miRNAs play a pivotal role in viral infection (<xref ref-type="bibr" rid="B64">Trobaugh and Klimstra, 2017</xref>). To explore the effect of miR-221-3p on DTMUV replication, we performed DEF transfected with miR-221-3p mimic or inhibitor and then followed it with DTMUV infection. Viral replication levels were determined through measuring viral copy number, E protein level, and viral titer. Results showed the viral copy number was significantly higher in the cells transfected with mimic than the cells transfected with mimic-NC (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Conversely, the viral copy number in inhibitor transfected cells was significantly lower than the inhibitor-NC transfected cells (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Subsequently, we tested the effects of miR-221-3p mimic and inhibitor on the DTMUV E protein expression level. As shown in <xref ref-type="fig" rid="F3">Figures 3B,C</xref>, the E protein expression was increased in mimic-treated cells as compared with mimic-NC-treated cells, and the E protein expression was decreased in inhibitor-treated cells compared with inhibitor-NC cells. Furthermore, we tested whether overexpression or inhibition of miR-221-3p could affect viral titer by TCID<sub>50</sub> assays. The results showed that viral titer in mimic transfected cells was enhanced than the mimic-NC group, and the viral titer was decreased by the inhibitor transfection (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Taken together, overexpression of miR-221-3p enhanced DTMUV replication and inhibition of miR-221-3p attenuated DTMUV replication. Thus, miR-221-3p could positively regulate DTMUV replication.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Overexpression of miR-221-3p facilitated duck Tembusu virus (DTMUV) replication. miR-221-3p mimic, inhibitor, and their respective controls were transfected into duck embryo fibroblast (DEF) cells. After 24 h of transfection, the cells were infected with DTMUV at a multiplicity of infection (MOI) of 1. <bold>(A)</bold> The cells were collected after 36 h of infection, and RNA was extracted using RNAiso reagent. The viral RNA level was determined by qRT-PCR. <bold>(B,C)</bold> The cells were lysed using radioimmunoprecipitation assay (RIPA) lysis buffer at 36 h post infection. The E protein and &#x03B2;-actin expression were detected by western blot. &#x03B2;-Actin expression was used as an internal control. The relative level of E protein expression was calculated as follows: the band density of E protein in each sample/that of &#x03B2;-actin in the same sample. <bold>(D)</bold> The cells were harvested at 60 h post infection for TCID<sub>50</sub>. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;<italic>P</italic> &#x003C; 0.05 and &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS4">
<title>Duck Tembusu Virus Infection Downregulated the Expression of Suppressor of Cytokine Signaling 5</title>
<p>As we found DTMUV infection upregulated miR-221-3p expression, therefore, we considered that the upregulation of miR-221-3p may inhibit the expression of some host genes involved in DTMUV replication. Therefore, we predicted the potential target genes of miR-221-3p through bioinformatics analysis. SOCS5, a negative regulator of cytokines, attracted our attention. Then, we detected the expression of SOCS5 in DEF infected with DTMUV at 36 h <italic>via</italic> qRT-PCR analysis. As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, the mRNA level of SOCS5 was reduced in DTMUV-infected DEF compared with the control group. Thus, DTMUV infection downregulated SOCS5 expression in DEF.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Duck Tembusu virus (DTMUV) infection downregulated suppressor of cytokine signaling 5 (SOCS5) expression in duck embryo fibroblast (DEF). The DEFs were plated in 6-well plates and infected with DTMUV at multiplicity of infection (MOI) = 1. Then, the cells were collected at 36 h post infection. The SOCS5 expression level was detected by qRT-PCR analysis. &#x03B2;-Actin was used as an internal reference. All experiments were performed in triplicate (<italic>n</italic> = 4). &#x002A;<italic>P</italic> &#x003C; 0.05 indicates statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g004.tif"/>
</fig>
</sec>
<sec id="S3.SS5">
<title>Suppressor of Cytokine Signaling 5 Is a Target of miR-221-3p</title>
<p>The bioinformatics analysis showed that a putative binding site was found in the 3&#x2032;-UTR of SOCS5 (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Then we constructed the recombinant luciferase plasmids including SOCS5 3&#x2032;-UTR wide-type or mutant-type using pmirGLO luciferase plasmid. The dual-luciferase reporter analysis showed that the relative luciferase activity was reduced in DEF treated with pmirGLO-SOCS5-Wt and miR-221-3p mimic compared with the mimic-NC group, and miR-221-3p inhibitor could significantly elevate the relative luciferase activity, whereas miR-221-3p mimic and inhibitor failed to significantly change the relative luciferase activity in DEF containing with the pmirGLO-SOCS5-Mut, compared with their respective control groups (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Therefore, these results indicated that SOCS5 is a target of miR-221-3p.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Suppressor of cytokine signaling 5 (SOCS5) is a potential target of miR-221-3p. <bold>(A)</bold> The schematic diagram showing the complementary sequences of the miR-221-3p binding site in the SOCS5 3&#x2032;-UTR. The mutant binding sites are indicated in red letters. <bold>(B)</bold> The duck embryo fibroblast (DEF) cells were co-transfected with mimic, mimic-NC, inhibitor, and inhibitor-NC together with pmirGLO-SOCS5-Wt or pmirGLO-SOCS5-Mut. After 48 h of transfection, the cells were collected, and the luciferase activities were detected by dual-luciferase assays. All experiments were performed in triplicate (<italic>n</italic> = 3). ns indicates non-significance of difference. &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS6">
<title>miR-221-3p Reduced Suppressor of Cytokine Signaling 5 Expression at mRNA and Protein Levels</title>
<p>We further determined whether miR-221-3p affects the mRNA and protein expression of SOCS5. The mimic or inhibitor was transfected into DEF for 48 h, then the SOCS5 mRNA level was detected <italic>via</italic> qRT-PCR, and the protein level was detected by western blot. As shown in <xref ref-type="fig" rid="F6">Figure 6A</xref>, the SOCS5 mRNA expression was significantly decreased in mimic transfected cells compared with mimic-NC transfected cells, whereas the SOCS5 mRNA expression was improved in the inhibitor transfected cells. In accordance with the qRT-PCR results, western blot analysis showed that the SOCS5 protein expression was reduced by mimic transfection and the SOCS5 protein level was increased by inhibitor transfection (<xref ref-type="fig" rid="F6">Figures 6B,C</xref>). Taken together, miR-221-3p could downregulate SOCS5 expression at mRNA and protein levels.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>miR-221-3p downregulated the expression of suppressor of cytokine signaling 5 (SOCS5). Duck embryo fibroblast (DEF) cells were transfected with mimic, mimic-NC, inhibitor, and inhibitor-NC for 48 h. <bold>(A)</bold> The SOCS5 mRNA level was determined by qRT-PCR. <bold>(B,C)</bold> The SOCS5 protein level was detected by western blot. &#x03B2;-Actin expression was used as an internal control. The relative level of SOCS5 protein expression was calculated as follows: the band density of SOCS5 protein in each sample/that of &#x03B2;-actin in the same sample. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g006.tif"/>
</fig>
</sec>
<sec id="S3.SS7">
<title>Knockdown and Overexpression of Suppressor of Cytokine Signaling 5</title>
<p>To examine the effect of the target SOCS5 gene during DTMUV infection, three shRNAs against SOCS5 were synthesized, and pcDNA3.1(+)-SOCS5 plasmid was constructed and then transfected into DEF. The SOCS5 expression was detected <italic>via</italic> qRT-PCR and western blot. The qRT-PCR results showed that SOCS5 mRNA expression was reduced after transfection with shRNA-1486, and SOCS5 mRNA expression was increased by pcDNA3.1(+)-SOCS5 plasmid transfection (<xref ref-type="fig" rid="F7">Figures 7A,B</xref>). In agreement with qRT-PCR results, the western blot results also showed that SOCS5 protein expression was reduced by SOCS5 shRNA-1486 transfection and that SOCS5 protein expression was increased by pcDNA3.1(+)-SOCS5 plasmid transfection (<xref ref-type="fig" rid="F7">Figures 7C,D</xref>). Therefore, these results proved that knockdown and overexpression of SOCS5 were successful.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>Knockdown and overexpression suppressor of cytokine signaling 5 (SOCS5). Duck embryo fibroblast (DEF) cells were transfected with con-shRNA, SOCS5 shRNAs, pcDNA3.1(+), and pcDNA3.1(+)-SOCS5 plasmids for 48 h. The SOCS5 mRNA expression level was determined by qRT-PCR. The differences of expression were determined using 2<sup>&#x2013;&#x0394;&#x0394;CT</sup> method <bold>(A,B)</bold>. The SOCS5 protein expression level was measured by western blot. &#x03B2;-Actin expression was used as an internal control. The relative level of SOCS5 protein expression was calculated as follows: the band density of SOCS5 protein in each sample/that of &#x03B2;-actin in the same sample <bold>(C,D)</bold>. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;<italic>P</italic> &#x003C; 0.05, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g007.tif"/>
</fig>
</sec>
<sec id="S3.SS8">
<title>Knockdown of Suppressor of Cytokine Signaling 5 Enhanced Duck Tembusu Virus Replication</title>
<p>We further detected the effect of SOCS5 on DTMUV replication. SOCS5 shRNA and pcDNA3.1(+)-SOCS5 were transfected into DEF and infected with DTMUV. The effect of SOCS5 on DTMUV replication was detected by qRT-PCR, TCID<sub>50</sub>, and western blot. The qRT-PCR and TCID<sub>50</sub> results showed that the viral RNA copies and viral titer were significantly increased after knockdown of SOCS5 by transfecting SOCS5 shRNA-1486 (<xref ref-type="fig" rid="F8">Figures 8A,B</xref>). In contrast, the viral RNA copies and viral titer were significantly decreased after overexpression of SOCS5 by transfecting pcDNA3.1(+)-SOCS5 (<xref ref-type="fig" rid="F8">Figures 8A,B</xref>). The western blot results showed that DTMUV E protein expression was significantly increased after knockdown of SOCS5 and that DTMUV E protein expression was significantly decreased after overexpression of SOCS5 (<xref ref-type="fig" rid="F8">Figures 8C,D</xref>). These results indicated that overexpression of SOCS5 could inhibit DTMUV replication and that knockdown of SOCS5 could enhance DTMUV replication.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption><p>Suppressor of cytokine signaling 5 (SOCS5) inhibited Duck Tembusu virus (DTMUV) replication. Con-shRNA, SOCS5 shRNA-1486, pcDNA3.1(+), and pcDNA3.1(+)-SOCS5 plasmids were transfected into duck embryo fibroblast (DEF) for 24 h, followed by DTMUV infection at multiplicity of infection (MOI) = 1. After 36 h of infection, the viral RNA copies were determined by qRT-PCR <bold>(A)</bold>. After 60 h of infection, the cells were harvested for TCID<sub>50</sub> <bold>(B)</bold>. After 36 h of infection, the viral E protein expression level was detected by western blot. &#x03B2;-Actin expression was used as an internal control. The relative level of E protein expression was calculated as follows: the band density of E protein in each sample/that of &#x03B2;-actin in the same sample <bold>(C,D)</bold>. All experiments were performed in triplicate (<italic>n</italic> = 3). &#x002A;<italic>P</italic> &#x003C; 0.05 and &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 indicate statistically significant difference using Student&#x2019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fmicb-11-00596-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>To date, there is increasing evidence that miRNAs play critical roles in viral replication and immune response. Our laboratory recently identified that 48 miRNAs were significantly differentially expressed in DEF upon DTMUV infection compared with uninfected DEF cells, and these dysregulated miRNAs may be involved in host&#x2013;virus interaction (<xref ref-type="bibr" rid="B9">Cui et al., 2018</xref>). In this study, we further investigated the role of a significantly upregulated miR-221-3p in DTMUV replication. We indicated that overexpression of miR-221-3p decreased IFN-&#x03B2; production and promoted DTMUV replication. In detail, miR-221-3p could target SOCS5 functionally and inhibit its expression. Furthermore, we found that knockdown of the expression of SOCS5 promoted viral replication (<xref ref-type="fig" rid="F9">Figure 9</xref>). To our knowledge, this is the first study that proved the regulatory relationship between cellular miR-221-3p and DTMUV replication. Therefore, our findings provide evidence that DTMUV increased the reproduction and proliferation of the virus itself by upregulating miR-221-3p, which represents a novel strategy adopted by DTMUV to evade host protective immune response that allows these organisms to survive.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption><p>The schematic representation of the relationship between duck Tembusu virus (DTMUV) infection, miR-221-3p, and suppressor of cytokine signaling 5 (SOCS5) expression. DTMUV infection upregulated the expression of miR-221-3p. Overexpression of miR-221-3p inhibited the expression of its target, SOCS5. Suppression of SOCS5 promoted DTMUV replication. The thick orange arrows indicate the upregulation or downregulation of gene expression. The thick orange arrows indicate the positive or negative effect.</p></caption>
<graphic xlink:href="fmicb-11-00596-g009.tif"/>
</fig>
<p>It is well known that miRNAs could modulate viral replication <italic>via</italic> two distinct mechanisms. Recent studies indicated miRNAs could target viral genome to directly inhibit or promote viral replication. For example, miR-23, miR-378, and miR-505 inhibited PRRSV replication through binding to the viral genome (<xref ref-type="bibr" rid="B79">Zhang et al., 2014</xref>). miR-122 facilitated HCV replication <italic>via</italic> direct interaction with viral RNA (<xref ref-type="bibr" rid="B40">Norman and Peter, 2010</xref>). miR-281 enhanced DENV-2 replication through the interaction between the seed regions of miR-281 and the 5&#x2032;-UTR of the DENV-2 sequence (<xref ref-type="bibr" rid="B81">Zhou et al., 2014</xref>). However, the binding sites of miR-221-3p in DTMUV UTR were not found in our bioinformatics analysis results. Of particular note, increasing studies showed that miRNAs indirectly modulated viral infection <italic>via</italic> targeting some host genes. For instance, upregulation of miR-146a enhanced JEV infection <italic>via</italic> targeting TRAF6, IRAK1, and IRAK2 (<xref ref-type="bibr" rid="B53">Sharma et al., 2015</xref>). Overexpression of miR-23b facilitated ALV-J replication <italic>via</italic> downregulating IRF1 (<xref ref-type="bibr" rid="B32">Li et al., 2015</xref>). In accordance with these results, we also indicated that overexpression of miR-221-3p reduced the IFN-&#x03B2; production and facilitated DTMUV replication. In a word, our results showed that the increased miR-221-3p during DTMUV infection negatively regulated IFN production and enhanced DTMUV replication. Therefore, we considered that miR-221-3p may target host genes that associated with the innate immune response to affect DTMUV replication. It is intriguing to further investigate the interaction mechanism of miR-221-3p in DTMUV infection.</p>
<p>Viral infection triggers the innate immune response (<xref ref-type="bibr" rid="B49">Satoshi and Shizuo, 2006</xref>; <xref ref-type="bibr" rid="B29">Koyama et al., 2008</xref>). Moreover, viral-induced immune response is also closely related to miRNAs-mediated post-transcriptional gene silencing mechanism (<xref ref-type="bibr" rid="B72">Xiao and Rajewsky, 2009</xref>; <xref ref-type="bibr" rid="B6">Chang Zheng et al., 2013</xref>; <xref ref-type="bibr" rid="B22">Islam et al., 2019</xref>; <xref ref-type="bibr" rid="B45">Rastogi and Singh, 2019</xref>). SOCS5, a negative regulator of cytokine and growth factor signaling, belonging to the SOCS family (<xref ref-type="bibr" rid="B78">Yoh Ichi et al., 2002</xref>; <xref ref-type="bibr" rid="B14">Edith et al., 2005</xref>; <xref ref-type="bibr" rid="B39">Nicholson et al., 2005</xref>; <xref ref-type="bibr" rid="B27">Kedzierski et al., 2017</xref>). SOCS proteins were involved in regulating immune response, tumorigenesis, and viral pathogenesis (<xref ref-type="bibr" rid="B47">Rottapel et al., 2002</xref>; <xref ref-type="bibr" rid="B1">Alexander and Hilton, 2004</xref>; <xref ref-type="bibr" rid="B36">Lisa Nowoslawski and Benveniste, 2011</xref>; <xref ref-type="bibr" rid="B76">Yakass et al., 2019</xref>). There are eight members of the SOCS family, including cytokine inducible SH2-containing protein (CISH) and SOCS1-7 (<xref ref-type="bibr" rid="B10">Delgado-Ortega et al., 2011</xref>; <xref ref-type="bibr" rid="B13">Duncan et al., 2017</xref>; <xref ref-type="bibr" rid="B68">Wang B. et al., 2019</xref>). Currently, a growing body of evidence has demonstrated that miRNAs level negatively correlated with SOCS protein expression (<xref ref-type="bibr" rid="B42">Peng et al., 2011</xref>; <xref ref-type="bibr" rid="B25">Jun et al., 2012</xref>; <xref ref-type="bibr" rid="B77">Yao et al., 2012</xref>; <xref ref-type="bibr" rid="B69">Wang X. et al., 2019</xref>). For instance, the expression of SOCS5 was inhibited by several miRNAs, such as miR-432, miR-301a, miR-130b, miR-124, miR-33-5p, miR-885-5p, and miR-132 (<xref ref-type="bibr" rid="B51">Shan et al., 2014</xref>; <xref ref-type="bibr" rid="B52">Sharma et al., 2016</xref>; <xref ref-type="bibr" rid="B18">Fu et al., 2017</xref>; <xref ref-type="bibr" rid="B19">Hazra et al., 2017</xref>; <xref ref-type="bibr" rid="B11">Diao et al., 2018</xref>; <xref ref-type="bibr" rid="B58">Su et al., 2018</xref>; <xref ref-type="bibr" rid="B65">Tsai et al., 2018</xref>). miR-432 inhibited JEV replication <italic>via</italic> regulating JAK-STAT signaling by targeting SOCS5, but another report indicated that miR-301a enhanced JEV replication through regulating EGFR signaling <italic>via</italic> targeting SOCS5 (<xref ref-type="bibr" rid="B52">Sharma et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Hazra et al., 2017</xref>). The dysregulation of these miRNAs caused the change of SOCS5 expression, resulting in the modulation of JAK-STAT and EGFR signaling, thus regulating the immune response. Previous studies have demonstrated that SOCS5 is a negative regulator of host immune response by modulating JAK-STAT signaling to inhibit IFN response (<xref ref-type="bibr" rid="B78">Yoh Ichi et al., 2002</xref>; <xref ref-type="bibr" rid="B21">Hwang et al., 2007</xref>; <xref ref-type="bibr" rid="B35">Linossi et al., 2013</xref>). However, recent studies also indicated SOCS5 as a negative regulator of EGFR signaling to promote IRF1-mediated IFN response (<xref ref-type="bibr" rid="B39">Nicholson et al., 2005</xref>; <xref ref-type="bibr" rid="B27">Kedzierski et al., 2017</xref>). In our study, we indicated that SOCS5 was a direct target of miR-221-3p in DEF upon DTMUV infection, and knockdown of the expression of SOCS5 enhanced DTMUV replication. Taken together, our results showed that miR-221-3p could facilitate DTMUV replication <italic>via</italic> downregulating SOCS5. We speculated that DTMUV induced miR-221-3p expression <italic>via</italic> related molecular pathways during DTMUV infection, and then miR-221-3p targeted SOCS5 and inhibited its expression, which thus might enhance EGFR activity. The activation of EGFR may affect the expression and phosphorylation of IRF-7 of duck, resulting in inhibition of IFN-&#x03B2; (<xref ref-type="bibr" rid="B7">Chen et al., 2018</xref>). Inhibition of IFN-&#x03B2; weakens host innate immune response and facilitates the proliferation of the virus. The functional mechanism of miR-221-3p and SOCS5 in immune response and viral infection still requires further investigation.</p>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>Taken together, we identified that DTMUV infection upregulated miR-221-3p expression, and we proved that the upregulation of miR-221-3p inhibited IFN production and enhanced DTMUV replication. Then, we further found that SOCS5 was a direct target of miR-221-3p and that miR-221-3p negatively regulated SOCS5 expression. Knockdown of SOCS5 could facilitate DTMUV replication. To our knowledge, this is the first study investigating the effect of miRNAs on DTMUV replication. The current study provides a new perspective for better understanding of host&#x2013;virus interaction mechanisms and may provide a new strategy to design miRNA-based vaccines and therapies.</p>
</sec>
<sec id="S6">
<title>Data Availability Statement</title>
<p>The datasets generated for this study are available on request to the corresponding author.</p>
</sec>
<sec id="S7">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Animal Ethics Committee of Sichuan Agricultural University (approval no. XF2016-17).</p>
</sec>
<sec id="S8">
<title>Author Contributions</title>
<p>MC, SZ, AC, and RJ conceived and designed the experiments. MC and SC performed the experiments. MC, YP, XCZ, and ZH analyzed the data. MC and SZ wrote the manuscript. JH, MW, DZ, SLC, ML, XXZ, YW, QY, YL, LZ, YY, ZY, BJ, MR, BT, and LP revised the manuscript. All authors edited and approved the final manuscript.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (31872475 and 31902267), Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System (SCCXTD-2020-18), China Agricultural Research System (CARS-42-17), and Sichuan Province Research Programs (2017JY0014/2018NZ0005).</p>
</fn>
</fn-group>
<ack>
<p>We would like to thank our funding sources and the assistance on bioinformatics analysis provided by Chengdu Basebiotech Co., Ltd.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>W. S.</given-names></name> <name><surname>Hilton</surname> <given-names>D. J.</given-names></name></person-group> (<year>2004</year>). <article-title>The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response.</article-title> <source><italic>Annu. Rev. Immunol.</italic></source> <volume>22</volume> <fpage>503</fpage>&#x2013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.22.091003.090312</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Annie</surname> <given-names>B.</given-names></name> <name><surname>Selena</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>The diverse roles of microRNAs at the host&#x2013;virus interface.</article-title> <source><italic>Viruses</italic></source> <volume>10</volume> <fpage>440</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.3390/v10080440</pub-id> <pub-id pub-id-type="pmid">30126238</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname> <given-names>D. P.</given-names></name></person-group> (<year>2004</year>). <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function.</article-title> <source><italic>Cell</italic></source> <volume>116</volume> <fpage>281</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(04)00045-5</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castrillon-Betancur</surname> <given-names>J. C.</given-names></name> <name><surname>Urcuqui-Inchima</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Overexpression of miR-484 and miR-744 in Vero cells alters Dengue virus replication.</article-title> <source><italic>Mem&#x00F3;rias Instit. Oswaldo Cruz.</italic></source> <volume>112</volume> <fpage>281</fpage>&#x2013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1590/0074-02760160404</pub-id> <pub-id pub-id-type="pmid">28327787</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname> <given-names>F. L.</given-names></name> <name><surname>Geddes</surname> <given-names>V. E. V.</given-names></name> <name><surname>Monteiro</surname> <given-names>F. L. L.</given-names></name> <name><surname>Goncalves</surname> <given-names>R.</given-names></name> <name><surname>Campanati</surname> <given-names>L.</given-names></name> <name><surname>Pezzuto</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection.</article-title> <source><italic>Am. Soc. Neurochem.</italic></source> <volume>11</volume> <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1177/1759091419850983</pub-id> <pub-id pub-id-type="pmid">31213064</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang Zheng</surname> <given-names>C.</given-names></name> <name><surname>Steven</surname> <given-names>S.</given-names></name> <name><surname>Rita</surname> <given-names>F.</given-names></name> <name><surname>Christina</surname> <given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of immune responses and tolerance: the microRNA perspective.</article-title> <source><italic>Immunol. Rev.</italic></source> <volume>253</volume> <fpage>112</fpage>&#x2013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12060</pub-id> <pub-id pub-id-type="pmid">23550642</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>P.</given-names></name> <name><surname>Yang</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Jia</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Duck interferon regulatory factor 7 (IRF7) can control duck Tembusu virus (DTMUV) infection by triggering type I interferon production and its signal transduction pathway.</article-title> <source><italic>Cytokine</italic></source> <volume>113</volume> <fpage>31</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2018.06.001</pub-id> <pub-id pub-id-type="pmid">29885990</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>W. X.</given-names></name> <name><surname>Hu</surname> <given-names>Q.</given-names></name> <name><surname>Qiu</surname> <given-names>M. T.</given-names></name> <name><surname>Zhong</surname> <given-names>S. L.</given-names></name> <name><surname>Xu</surname> <given-names>J. J.</given-names></name> <name><surname>Tang</surname> <given-names>J. H.</given-names></name></person-group> (<year>2013</year>). <article-title>miR-221/222: promising biomarkers for breast cancer.</article-title> <source><italic>Tumor Biol.</italic></source> <volume>34</volume> <fpage>1361</fpage>&#x2013;<lpage>1370</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-013-0750-y</pub-id> <pub-id pub-id-type="pmid">23529451</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>M.</given-names></name> <name><surname>Jia</surname> <given-names>R.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Hu</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Analysis of the microRNA expression profiles in DEF cells infected with duck <italic>Tembusu</italic> virus.</article-title> <source><italic>Infect. Genet. Evol.</italic></source> <volume>63</volume> <fpage>126</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2018.05.020</pub-id> <pub-id pub-id-type="pmid">29803008</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado-Ortega</surname> <given-names>M.</given-names></name> <name><surname>Melo</surname> <given-names>S.</given-names></name> <name><surname>Meurens</surname> <given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Expression of SOCS1-7 and CIS mRNA in porcine tissues.</article-title> <source><italic>Vet. Immunol. Immunopathol.</italic></source> <volume>144</volume> <fpage>493</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetimm.2011.08.002</pub-id> <pub-id pub-id-type="pmid">21872343</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname> <given-names>X.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Ma</surname> <given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Upregulation of miR-132 contributes to the pathophysiology of COPD via targeting SOCS5.</article-title> <source><italic>Exp. Mol. Pathol.</italic></source> <volume>105</volume> <fpage>285</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexmp.2018.10.002</pub-id> <pub-id pub-id-type="pmid">30292646</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>H.</given-names></name> <name><surname>Cui</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>G.</given-names></name> <name><surname>Wang</surname> <given-names>P.</given-names></name> <name><surname>Fikrig</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>MiR-221 negatively regulates innate anti-viral response.</article-title> <source><italic>PLoS One</italic></source> <volume>13</volume>:<issue>e0200385</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0200385</pub-id> <pub-id pub-id-type="pmid">30089112</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname> <given-names>S. A.</given-names></name> <name><surname>Baganizi</surname> <given-names>D. R.</given-names></name> <name><surname>Sahu</surname> <given-names>R.</given-names></name> <name><surname>Singh</surname> <given-names>S. R.</given-names></name> <name><surname>Dennis</surname> <given-names>V. A.</given-names></name></person-group> (<year>2017</year>). <article-title>SOCS proteins as regulators of inflammatory responses induced by bacterial infections: a review.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>8</volume>:<fpage>2431</fpage>&#x2013;<lpage>2446</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02431</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edith</surname> <given-names>K.</given-names></name> <name><surname>Marmor</surname> <given-names>M. D.</given-names></name> <name><surname>Konstantin</surname> <given-names>A.</given-names></name> <name><surname>Ami</surname> <given-names>C.</given-names></name> <name><surname>Ido</surname> <given-names>A.</given-names></name> <name><surname>Ninette</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>280</volume> <fpage>7038</fpage>&#x2013;<lpage>7048</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M408575200</pub-id> <pub-id pub-id-type="pmid">15590694</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escalera-Cueto</surname> <given-names>M.</given-names></name> <name><surname>Medina-Martinez</surname> <given-names>I.</given-names></name> <name><surname>del Angel</surname> <given-names>R. M.</given-names></name> <name><surname>Berumen-Campos</surname> <given-names>J.</given-names></name> <name><surname>Gutierrez-Escolano</surname> <given-names>A. L.</given-names></name> <name><surname>Yocupicio-Monroy</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Let-7c overexpression inhibits dengue virus replication in human hepatoma Huh-7 cells.</article-title> <source><italic>Virus Res.</italic></source> <volume>196</volume> <fpage>105</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2014.11.010</pub-id> <pub-id pub-id-type="pmid">25445350</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabbri</surname> <given-names>M.</given-names></name> <name><surname>Croce</surname> <given-names>C. M.</given-names></name> <name><surname>Calin</surname> <given-names>G. A.</given-names></name></person-group> (<year>2007</year>). <article-title>MicroRNAs.</article-title> <source><italic>Cancer J.</italic></source> <volume>14</volume> <fpage>759</fpage>&#x2013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1097/PPO.0b013e318164145e</pub-id> <pub-id pub-id-type="pmid">18303474</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname> <given-names>S. C.</given-names></name> <name><surname>Tate</surname> <given-names>M. D.</given-names></name> <name><surname>Hertzog</surname> <given-names>P. J.</given-names></name></person-group> (<year>2015</year>). <article-title>MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response.</article-title> <source><italic>Front. Immunol.</italic></source> <volume>6</volume>:<issue>334</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00334</pub-id> <pub-id pub-id-type="pmid">26217335</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>He</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>microRNA gga-miR-130b suppresses infectious bursal disease virus replication via targeting of the viral genome and cellular suppressors of cytokine signaling 5.</article-title> <source><italic>J. Virol.</italic></source> <volume>92</volume> <fpage>1646</fpage>&#x2013;<lpage>1617</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01646-17</pub-id> <pub-id pub-id-type="pmid">29046449</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hazra</surname> <given-names>B.</given-names></name> <name><surname>Kumawat</surname> <given-names>K. L.</given-names></name> <name><surname>Basu</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>The host microRNA miR-301a blocks the IRF1-mediated neuronal innate immune response to Japanese encephalitis virus infection.</article-title> <source><italic>Sci. Signal.</italic></source> <volume>10</volume>:<issue>eaaf5185</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.aaf5185</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname> <given-names>H. A. M.</given-names></name> <name><surname>Alfhili</surname> <given-names>M. A.</given-names></name> <name><surname>Pakala</surname> <given-names>P.</given-names></name> <name><surname>Simon</surname> <given-names>S.</given-names></name> <name><surname>Hussain</surname> <given-names>J.</given-names></name> <name><surname>McCubrey</surname> <given-names>J. A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>miRNAs and their roles in KSHV pathogenesis.</article-title> <source><italic>Virus Res.</italic></source> <volume>266</volume> <fpage>15</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2019.03.024</pub-id> <pub-id pub-id-type="pmid">30951791</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>M. N.</given-names></name> <name><surname>Kim</surname> <given-names>K. S.</given-names></name> <name><surname>Choi</surname> <given-names>Y. W.</given-names></name> <name><surname>Jou</surname> <given-names>I.</given-names></name> <name><surname>Yoon</surname> <given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>PMA activates Stat3 in the Jak/Stat pathway and induces SOCS5 in rat brain astrocytes.</article-title> <source><italic>Mol. Cells</italic></source> <volume>23</volume> <fpage>94</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00216.x</pub-id> <pub-id pub-id-type="pmid">17352761</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname> <given-names>M. S.</given-names></name> <name><surname>Khan</surname> <given-names>M. A. A.</given-names></name> <name><surname>Murad</surname> <given-names>M. W.</given-names></name> <name><surname>Karim</surname> <given-names>M.</given-names></name> <name><surname>Islam</surname> <given-names>A. B. M. M. K.</given-names></name></person-group> (<year>2019</year>). <article-title>In silico analysis revealed Zika virus miRNAs associated with viral pathogenesis through alteration of host genes involved in immune response and neurological functions.</article-title> <source><italic>J. Med. Virol.</italic></source> <volume>91</volume> <fpage>1584</fpage>&#x2013;<lpage>1594</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25505</pub-id> <pub-id pub-id-type="pmid">31095749</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname> <given-names>R.</given-names></name> <name><surname>Huahui</surname> <given-names>S.</given-names></name> <name><surname>Hongxia</surname> <given-names>F.</given-names></name> <name><surname>Chunmei</surname> <given-names>W.</given-names></name> <name><surname>Yixuan</surname> <given-names>L.</given-names></name> <name><surname>Min</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1.</article-title> <source><italic>PLoS One</italic></source> <volume>9</volume>:<issue>e114021</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0114021</pub-id> <pub-id pub-id-type="pmid">25461762</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jingliang</surname> <given-names>S.</given-names></name> <name><surname>Shuang</surname> <given-names>L.</given-names></name> <name><surname>Xudong</surname> <given-names>H.</given-names></name> <name><surname>Xiuling</surname> <given-names>Y.</given-names></name> <name><surname>Yongyue</surname> <given-names>W.</given-names></name> <name><surname>Peipei</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Duck egg-drop syndrome caused by BYD virus, a new Tembusu-related flavivirus.</article-title> <source><italic>PLoS One</italic></source> <volume>6</volume>:<issue>e18106</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0018106</pub-id> <pub-id pub-id-type="pmid">21455312</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname> <given-names>Z.</given-names></name> <name><surname>Hongying</surname> <given-names>Z.</given-names></name> <name><surname>Jinping</surname> <given-names>C.</given-names></name> <name><surname>Bing</surname> <given-names>X.</given-names></name> <name><surname>Yongming</surname> <given-names>J.</given-names></name> <name><surname>Wei</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Interferon-&#x03B2;-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>586</volume> <fpage>3255</fpage>&#x2013;<lpage>3262</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2012.06.047</pub-id> <pub-id pub-id-type="pmid">22771905</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname> <given-names>T.</given-names></name> <name><surname>Komatsu</surname> <given-names>S.</given-names></name> <name><surname>Ichikawa</surname> <given-names>D.</given-names></name> <name><surname>Morimura</surname> <given-names>R.</given-names></name> <name><surname>Tsujiura</surname> <given-names>M.</given-names></name> <name><surname>Konishi</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.</article-title> <source><italic>Br. J. Cancer</italic></source> <volume>108</volume> <fpage>361</fpage>&#x2013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2012.546</pub-id> <pub-id pub-id-type="pmid">23329235</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kedzierski</surname> <given-names>L.</given-names></name> <name><surname>Tate</surname> <given-names>M. D.</given-names></name> <name><surname>Hsu</surname> <given-names>A. C.</given-names></name> <name><surname>Kolesnik</surname> <given-names>T. B.</given-names></name> <name><surname>Linossi</surname> <given-names>E. M.</given-names></name> <name><surname>Dagley</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling.</article-title> <source><italic>eLife</italic></source> <volume>6</volume>:<issue>e20444</issue>. <pub-id pub-id-type="doi">10.7554/eLife.20444</pub-id> <pub-id pub-id-type="pmid">28195529</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kincaid</surname> <given-names>R. P.</given-names></name> <name><surname>Sullivan</surname> <given-names>C. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Virus-encoded microRNAs: an overview and a look to the future.</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>8</volume>:<issue>e1003018</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003018</pub-id> <pub-id pub-id-type="pmid">23308061</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname> <given-names>S.</given-names></name> <name><surname>Ishii</surname> <given-names>K. J.</given-names></name> <name><surname>Coban</surname> <given-names>C.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Innate immune response to viral infection.</article-title> <source><italic>Cytokine</italic></source> <volume>43</volume> <fpage>336</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2008.07.009</pub-id> <pub-id pub-id-type="pmid">18694646</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krek</surname> <given-names>A.</given-names></name> <name><surname>Grun</surname> <given-names>D.</given-names></name> <name><surname>Mn, Wolf</surname> <given-names>R.</given-names></name> <name><surname>Rosenberg</surname> <given-names>L.</given-names></name> <name><surname>Epstein</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Combinatorial microRNA target predictions.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>37</volume> <fpage>495</fpage>&#x2013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/ng1536</pub-id> <pub-id pub-id-type="pmid">15806104</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lagos</surname> <given-names>D.</given-names></name> <name><surname>Pollara</surname> <given-names>G.</given-names></name> <name><surname>Henderson</surname> <given-names>S.</given-names></name> <name><surname>Gratrix</surname> <given-names>F.</given-names></name> <name><surname>Fabani</surname> <given-names>M.</given-names></name> <name><surname>Milne</surname> <given-names>R. S. B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.</article-title> <source><italic>Nat. Cell Biol.</italic></source> <volume>12</volume> <fpage>513</fpage>&#x2013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2054</pub-id> <pub-id pub-id-type="pmid">20418869</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Min</surname> <given-names>F.</given-names></name> <name><surname>Ouyang</surname> <given-names>H.</given-names></name> <name><surname>Ming</surname> <given-names>Z.</given-names></name> <name><surname>Qiao</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>MicroRNA-23b promotes avian leukosis virus subgroup J (ALV-J) replication by targeting IRF1.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>5</volume> <fpage>10294</fpage>&#x2013;<lpage>10307</lpage>. <pub-id pub-id-type="doi">10.1038/srep10294</pub-id> <pub-id pub-id-type="pmid">25980475</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Qingbin</surname> <given-names>L.</given-names></name> <name><surname>Haiping</surname> <given-names>X.</given-names></name> <name><surname>Ming</surname> <given-names>Z.</given-names></name> <name><surname>Ali</surname> <given-names>A. B.</given-names></name> <name><surname>Min</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>MiR-34b-5p suppresses melanoma differentiation-associated gene 5 (MDA5) signaling pathway to promote avian Leukosis Virus Subgroup J (ALV-J)-Infected Cells Proliferaction and ALV-J replication.</article-title> <source><italic>Front. Cell. Infect. Microbiol.</italic></source> <volume>7</volume>:<issue>17</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00017</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>H.</given-names></name> <name><surname>Hannon</surname> <given-names>G. J.</given-names></name></person-group> (<year>2004</year>). <article-title>MicroRNAs: small RNAs with a big role in gene regulation.</article-title> <source><italic>Nat. Rev. Genet.</italic></source> <volume>5</volume> <fpage>522</fpage>&#x2013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1379</pub-id> <pub-id pub-id-type="pmid">15211354</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linossi</surname> <given-names>E. M.</given-names></name> <name><surname>Chandrashekaran</surname> <given-names>I. R.</given-names></name> <name><surname>Kolesnik</surname> <given-names>T. B.</given-names></name> <name><surname>Murphy</surname> <given-names>J. M.</given-names></name> <name><surname>Webb</surname> <given-names>A. I.</given-names></name> <name><surname>Willson</surname> <given-names>T. A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<issue>e70536</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0070536</pub-id> <pub-id pub-id-type="pmid">23990909</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lisa Nowoslawski</surname> <given-names>A.</given-names></name> <name><surname>Benveniste</surname> <given-names>E. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Viral exploitation of host SOCS protein functions.</article-title> <source><italic>J. Virol.</italic></source> <volume>85</volume> <fpage>1912</fpage>&#x2013;<lpage>1921</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01857-10</pub-id> <pub-id pub-id-type="pmid">21084484</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>L. F.</given-names></name> <name><surname>Liston</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>MicroRNA in the immune system, microRNA as an immune system.</article-title> <source><italic>Insect Sci.</italic></source> <volume>127</volume> <fpage>291</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2009.03092.x</pub-id> <pub-id pub-id-type="pmid">19538248</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Momen-Heravi</surname> <given-names>F.</given-names></name> <name><surname>Bala</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>miRNA regulation of innate immunity.</article-title> <source><italic>J. Leukoc. Biol.</italic></source> <volume>103</volume> <fpage>1205</fpage>&#x2013;<lpage>1217</lpage>. <pub-id pub-id-type="doi">10.1002/JLB.3MIR1117-459R</pub-id> <pub-id pub-id-type="pmid">29656417</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname> <given-names>S. E.</given-names></name> <name><surname>Donald</surname> <given-names>M.</given-names></name> <name><surname>Sprigg</surname> <given-names>N. S.</given-names></name> <name><surname>Ruth</surname> <given-names>C.</given-names></name> <name><surname>Francesca</surname> <given-names>W.</given-names></name> <name><surname>Anabel</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>102</volume> <fpage>2328</fpage>&#x2013;<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409675102</pub-id> <pub-id pub-id-type="pmid">15695332</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname> <given-names>K. L.</given-names></name> <name><surname>Peter</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms.</article-title> <source><italic>J. Virol.</italic></source> <volume>84</volume> <fpage>666</fpage>&#x2013;<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01156-09</pub-id> <pub-id pub-id-type="pmid">19846523</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ojha</surname> <given-names>C. R.</given-names></name> <name><surname>Rodriguez</surname> <given-names>M.</given-names></name> <name><surname>Dever</surname> <given-names>S. M.</given-names></name> <name><surname>Mukhopadhyay</surname> <given-names>R.</given-names></name> <name><surname>El-Hage</surname> <given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections.</article-title> <source><italic>J. Biomed. Sci.</italic></source> <volume>23</volume> <fpage>74</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1186/s12929-016-0292-x</pub-id> <pub-id pub-id-type="pmid">27784307</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>R.</given-names></name> <name><surname>Robert</surname> <given-names>S.</given-names></name> <name><surname>Hsueh</surname> <given-names>E. C.</given-names></name> <name><surname>Ray</surname> <given-names>R. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity.</article-title> <source><italic>Genes Cancer</italic></source> <volume>2</volume> <fpage>720</fpage>&#x2013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1177/1947601911425832</pub-id> <pub-id pub-id-type="pmid">22207897</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pixi</surname> <given-names>Y.</given-names></name> <name><surname>Youshu</surname> <given-names>Z.</given-names></name> <name><surname>Xu</surname> <given-names>Z.</given-names></name> <name><surname>Dawei</surname> <given-names>X.</given-names></name> <name><surname>Xiaoguang</surname> <given-names>D.</given-names></name> <name><surname>Qiaoyang</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China.</article-title> <source><italic>Virology</italic></source> <volume>417</volume> <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2011.06.003</pub-id> <pub-id pub-id-type="pmid">21722935</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajewsky</surname> <given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>microRNA target predictions in animals.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>38</volume>(Suppl.), <fpage>S8</fpage>&#x2013;<lpage>S13</lpage>. <pub-id pub-id-type="doi">10.1038/ng1798</pub-id> <pub-id pub-id-type="pmid">16736023</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname> <given-names>M.</given-names></name> <name><surname>Singh</surname> <given-names>S. K.</given-names></name></person-group> (<year>2019</year>). <article-title>Modulation of type-I interferon response by hsa-miR-374b-5p during japanese encephalitis virus infection in human microglial cells.</article-title> <source><italic>Front. Cell. Infect. Microbiol.</italic></source> <volume>9</volume>:<issue>291</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2019.00291</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname> <given-names>L. J.</given-names></name> <name><surname>Muench</surname> <given-names>H.</given-names></name></person-group> (<year>1938</year>). <article-title>A simple method of estimating fifty percent endpoints.</article-title> <source><italic>Am. J. Epidemiol.</italic></source> <volume>27</volume> <fpage>493</fpage>&#x2013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rottapel</surname> <given-names>R.</given-names></name> <name><surname>Ilangumaran</surname> <given-names>S.</given-names></name> <name><surname>Neale</surname> <given-names>C.</given-names></name> <name><surname>La</surname> <given-names>R. J.</given-names></name> <name><surname>Ho</surname> <given-names>J. M.</given-names></name> <name><surname>Nguyen</surname> <given-names>M. H.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>The tumor suppressor activity of SOCS-1.</article-title> <source><italic>Oncogene</italic></source> <volume>21</volume> <fpage>4351</fpage>&#x2013;<lpage>4362</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1205537</pub-id> <pub-id pub-id-type="pmid">12080466</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sartorius</surname> <given-names>K.</given-names></name> <name><surname>Makarova</surname> <given-names>J.</given-names></name> <name><surname>Sartorius</surname> <given-names>B.</given-names></name> <name><surname>An</surname> <given-names>P.</given-names></name> <name><surname>Winkler</surname> <given-names>C.</given-names></name> <name><surname>Chuturgoon</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>The regulatory role of MicroRNA in Hepatitis-B Virus-associated hepatocellular carcinoma (HBV-HCC) pathogenesis.</article-title> <source><italic>Cells</italic></source> <volume>8</volume>:<issue>1504</issue>. <pub-id pub-id-type="doi">10.3390/cells8121504</pub-id> <pub-id pub-id-type="pmid">31771261</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satoshi</surname> <given-names>U.</given-names></name> <name><surname>Shizuo</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Innate immune recognition of viral infection.</article-title> <source><italic>Uirusu</italic></source> <volume>56</volume> <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ni1303</pub-id> <pub-id pub-id-type="pmid">16424890</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scaria</surname> <given-names>V.</given-names></name> <name><surname>Hariharan</surname> <given-names>M.</given-names></name> <name><surname>Maiti</surname> <given-names>S.</given-names></name> <name><surname>Pillai</surname> <given-names>B.</given-names></name> <name><surname>Brahmachari</surname> <given-names>S. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Host-virus interaction: a new role for microRNAs.</article-title> <source><italic>Retrovirology</italic></source> <volume>3</volume> <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/1742-4690-3-68</pub-id> <pub-id pub-id-type="pmid">17032463</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname> <given-names>J.</given-names></name> <name><surname>Chaoran</surname> <given-names>L.</given-names></name> <name><surname>Gabrielle</surname> <given-names>M. R.</given-names></name> <name><surname>Erik</surname> <given-names>L.</given-names></name> <name><surname>Jose</surname> <given-names>S.</given-names></name> <name><surname>Si-Qi</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.</article-title> <source><italic>Sci. Signal.</italic></source> <volume>7</volume>:<issue>ra25</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.2004824</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>N.</given-names></name> <name><surname>Kumawat</surname> <given-names>K. L.</given-names></name> <name><surname>Rastogi</surname> <given-names>M.</given-names></name> <name><surname>Basu</surname> <given-names>A.</given-names></name> <name><surname>Singh</surname> <given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Japanese Encephalitis Virus exploits the microRNA-432 to regulate the expression of Suppressor of Cytokine Signaling (SOCS) 5.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>6</volume> <fpage>27685</fpage>&#x2013;<lpage>27697</lpage>. <pub-id pub-id-type="doi">10.1038/srep27685</pub-id> <pub-id pub-id-type="pmid">27282499</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>N.</given-names></name> <name><surname>Verma</surname> <given-names>R.</given-names></name> <name><surname>Kumawat</surname> <given-names>K. L.</given-names></name> <name><surname>Basu</surname> <given-names>A.</given-names></name> <name><surname>Singh</surname> <given-names>S. K.</given-names></name></person-group> (<year>2015</year>). <article-title>miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells.</article-title> <source><italic>J. Neuroinflam.</italic></source> <volume>12</volume> <fpage>30</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0249-0</pub-id> <pub-id pub-id-type="pmid">25889446</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shilong</surname> <given-names>C.</given-names></name> <name><surname>Shao</surname> <given-names>W.</given-names></name> <name><surname>Zhaolong</surname> <given-names>L.</given-names></name> <name><surname>Fengqiang</surname> <given-names>L.</given-names></name> <name><surname>Xiaoxia</surname> <given-names>C.</given-names></name> <name><surname>Xiaoli</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Isolation and characterization of a Chinese strain of Tembusu virus from Hy-Line Brown layers with acute egg-drop syndrome in Fujian.</article-title> <source><italic>China. Arch. Virol.</italic></source> <volume>159</volume> <fpage>1099</fpage>&#x2013;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-013-1931-0</pub-id> <pub-id pub-id-type="pmid">24297489</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skalsky</surname> <given-names>R. L.</given-names></name> <name><surname>Cullen</surname> <given-names>B. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Viruses and MicroRNAs.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>38</volume>(Suppl.), <fpage>S25</fpage>&#x2013;<lpage>S30</lpage>. <pub-id pub-id-type="doi">10.1038/ng1793</pub-id> <pub-id pub-id-type="pmid">16736021</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slonchak</surname> <given-names>A.</given-names></name> <name><surname>Shannon</surname> <given-names>R. P.</given-names></name> <name><surname>Pali</surname> <given-names>G.</given-names></name> <name><surname>Khromykh</surname> <given-names>A. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Human MicroRNA miR-532-5p exhibits antiviral activity against west nile virus via suppression of host genes SESTD1 and TAB3 required for virus replication.</article-title> <source><italic>J. Virol.</italic></source> <volume>90</volume> <fpage>2388</fpage>&#x2013;<lpage>2402</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02608-15</pub-id> <pub-id pub-id-type="pmid">26676784</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>J. L.</given-names></name> <name><surname>Jeng</surname> <given-names>S.</given-names></name> <name><surname>McWeeney</surname> <given-names>S. K.</given-names></name> <name><surname>Hirsch</surname> <given-names>A. J.</given-names></name></person-group> (<year>2017</year>). <article-title>A MicroRNA Screen identifies the Wnt signaling pathway as a regulator of the interferon response during flavivirus infection.</article-title> <source><italic>J. Virol.</italic></source> <volume>91</volume> <fpage>e02388</fpage>&#x2013;<lpage>e02416</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02388-16</pub-id> <pub-id pub-id-type="pmid">28148804</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>M.</given-names></name> <name><surname>Qin</surname> <given-names>B.</given-names></name> <name><surname>Liu</surname> <given-names>F.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>miR-885-5p upregulation promotes colorectal cancer cell proliferation and migration by targeting suppressor of cytokine signaling.</article-title> <source><italic>Oncol. Lett.</italic></source> <volume>16</volume> <fpage>65</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2018.8645</pub-id> <pub-id pub-id-type="pmid">29928388</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>C. S.</given-names></name> <name><surname>Ganem</surname> <given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>MicroRNAs and viral infection.</article-title> <source><italic>Mol. Cell.</italic></source> <volume>20</volume> <fpage>3</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.012</pub-id> <pub-id pub-id-type="pmid">16209940</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>Y.</given-names></name> <name><surname>Diao</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>C.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Ju</surname> <given-names>X.</given-names></name> <name><surname>Xue</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2013a</year>). <article-title>Characterization of a Tembusu virus isolated from naturally infected house sparrows (<italic>Passer domesticus</italic>) in Northern China.</article-title> <source><italic>Transboundary Emerg. Dis.</italic></source> <volume>60</volume> <fpage>152</fpage>&#x2013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1111/j.1865-1682.2012.01328.x</pub-id> <pub-id pub-id-type="pmid">22515847</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>Y.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Diao</surname> <given-names>Y.</given-names></name> <name><surname>Feng</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2013b</year>). <article-title>Tembusu virus in human, china.</article-title> <source><italic>Transboundary Emerg. Dis.</italic></source> <volume>60</volume> <fpage>193</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1111/tbed.12085</pub-id> <pub-id pub-id-type="pmid">23551969</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>Y.</given-names></name> <name><surname>Dabing</surname> <given-names>Z.</given-names></name> <name><surname>Xuejun</surname> <given-names>M.</given-names></name> <name><surname>Zhenzhen</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Zheng</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Complete genome sequence of a novel flavivirus, duck tembusu virus, isolated from ducks and geese in china.</article-title> <source><italic>J. Virol.</italic></source> <volume>86</volume> <fpage>3406</fpage>&#x2013;<lpage>3417</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.07132-11</pub-id> <pub-id pub-id-type="pmid">22354945</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ti</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Zhao</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Effect of age and inoculation route on the infection of duck Tembusu virus in Goslings.</article-title> <source><italic>Vet. Microbiol.</italic></source> <volume>181</volume> <fpage>190</fpage>&#x2013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2015.10.001</pub-id> <pub-id pub-id-type="pmid">26476564</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trobaugh</surname> <given-names>D. W.</given-names></name> <name><surname>Klimstra</surname> <given-names>W. B.</given-names></name></person-group> (<year>2017</year>). <article-title>MicroRNA regulation of RNA virus replication and pathogenesis.</article-title> <source><italic>Trends Mol. Med</italic>.</source> <volume>23</volume> <fpage>80</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2016.11.003</pub-id> <pub-id pub-id-type="pmid">27989642</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname> <given-names>Y. C.</given-names></name> <name><surname>Kuo</surname> <given-names>P. L.</given-names></name> <name><surname>Hung</surname> <given-names>W. W.</given-names></name> <name><surname>Wu</surname> <given-names>L. Y.</given-names></name> <name><surname>Wu</surname> <given-names>P. H.</given-names></name> <name><surname>Chang</surname> <given-names>W. A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Angpt2 induces mesangial cell apoptosis through the MicroRNA-33-5p-SOCS5 Loop in diabetic nephropathy.</article-title> <source><italic>Mol. Ther. Nucleic Acids</italic></source> <volume>13</volume> <fpage>543</fpage>&#x2013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2018.10.003</pub-id> <pub-id pub-id-type="pmid">30414568</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urcuqui-Inchima</surname> <given-names>S.</given-names></name> <name><surname>Cabrera</surname> <given-names>J.</given-names></name> <name><surname>Haenni</surname> <given-names>A.-L.</given-names></name></person-group> (<year>2017</year>). <article-title>Interplay between dengue virus and Toll-like receptors, RIG-I/MDA5 and microRNAs: implications for pathogenesis.</article-title> <source><italic>Antiviral Res.</italic></source> <volume>147</volume> <fpage>47</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.09.017</pub-id> <pub-id pub-id-type="pmid">28965915</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname> <given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>The functions of animal microRNAs.</article-title> <source><italic>Nature</italic></source> <volume>431</volume> <fpage>350</fpage>&#x2013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1038/nature02871</pub-id> <pub-id pub-id-type="pmid">15372042</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Wangkahart</surname> <given-names>E.</given-names></name> <name><surname>Secombes</surname> <given-names>C. J.</given-names></name> <name><surname>Wang</surname> <given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>Insights into the evolution of the suppressors of cytokine signaling (SOCS) gene family in vertebrates.</article-title> <source><italic>Mol. Biol. Evol.</italic></source> <volume>36</volume> <fpage>393</fpage>&#x2013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msy230</pub-id> <pub-id pub-id-type="pmid">30521052</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Jia</surname> <given-names>Y.</given-names></name> <name><surname>Ren</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Xiao</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>MicroRNA gga-miR-455-5p suppresses Newcastle disease virus replication via targeting cellular suppressors of cytokine signaling 3.</article-title> <source><italic>Vet. Microbiol.</italic></source> <volume>239</volume>:<issue>108460</issue>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2019.108460</pub-id> <pub-id pub-id-type="pmid">31767079</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witwer</surname> <given-names>K. W.</given-names></name> <name><surname>Sisk</surname> <given-names>J. M.</given-names></name> <name><surname>Lucio</surname> <given-names>G.</given-names></name> <name><surname>Clements</surname> <given-names>J. E.</given-names></name></person-group> (<year>2010</year>). <article-title>MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response.</article-title> <source><italic>J. Immunol.</italic></source> <volume>184</volume>:<issue>2369</issue>. <pub-id pub-id-type="doi">10.4049/jimmunol.0902712</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>S.</given-names></name> <name><surname>He</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Feng</surname> <given-names>L.</given-names></name> <name><surname>Jiang</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6.</article-title> <source><italic>J. Infect.</italic></source> <volume>67</volume> <fpage>329</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2013.05.003</pub-id> <pub-id pub-id-type="pmid">23685241</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>C.</given-names></name> <name><surname>Rajewsky</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>MicroRNA control in the immune system: basic principles.</article-title> <source><italic>Cell</italic></source> <volume>136</volume> <fpage>26</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.12.027</pub-id> <pub-id pub-id-type="pmid">19135886</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing Xiang</surname> <given-names>P.</given-names></name> <name><surname>Guo Liang</surname> <given-names>H.</given-names></name> <name><surname>Hong Qiang</surname> <given-names>G.</given-names></name> <name><surname>Cheng Cheng</surname> <given-names>G.</given-names></name> <name><surname>Haoran</surname> <given-names>L.</given-names></name> <name><surname>Shen</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.</article-title> <source><italic>J. Gastroenterol. Hepatol.</italic></source> <volume>25</volume> <fpage>1674</fpage>&#x2013;<lpage>1680</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2010.06417.x</pub-id> <pub-id pub-id-type="pmid">20880178</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing Xing</surname> <given-names>H.</given-names></name> <name><surname>An Yuan</surname> <given-names>G.</given-names></name> <name><surname>Chuan Rui</surname> <given-names>X.</given-names></name> <name><surname>Ying</surname> <given-names>C.</given-names></name> <name><surname>Guang, Ya</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.</article-title> <source><italic>Oncol. Rep.</italic></source> <volume>32</volume> <fpage>1200</fpage>&#x2013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.3892/or.2014.3306</pub-id> <pub-id pub-id-type="pmid">24993451</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>G.</given-names></name> <name><surname>Yang</surname> <given-names>F.</given-names></name> <name><surname>Ding</surname> <given-names>C. L.</given-names></name> <name><surname>Jing</surname> <given-names>W.</given-names></name> <name><surname>Ping</surname> <given-names>Z.</given-names></name> <name><surname>Wen</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>MiR-221 accentuates IFN&#x00D7;s anti-HCV effect by downregulating SOCS1 and SOCS3.</article-title> <source><italic>Virology</italic></source> <volume>462</volume> <fpage>343</fpage>&#x2013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2014.06.024</pub-id> <pub-id pub-id-type="pmid">25019494</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yakass</surname> <given-names>M. B.</given-names></name> <name><surname>Franco</surname> <given-names>D.</given-names></name> <name><surname>Quaye</surname> <given-names>O.</given-names></name></person-group> (<year>2019</year>). <article-title>Suppressors of cytokine signaling and protein inhibitors of activated signal transducer and activator of transcriptions as therapeutic targets in flavivirus infections.</article-title> <source><italic>J. Interf. Cytokine Res.</italic></source> <volume>00</volume> <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2019.0097</pub-id> <pub-id pub-id-type="pmid">31436502</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>R.</given-names></name> <name><surname>Ma</surname> <given-names>Y. L.</given-names></name> <name><surname>Liang</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>H. H.</given-names></name> <name><surname>Ma</surname> <given-names>Z. J.</given-names></name> <name><surname>Yu</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e46082</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046082</pub-id> <pub-id pub-id-type="pmid">23091595</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoh Ichi</surname> <given-names>S.</given-names></name> <name><surname>Katsuhiko</surname> <given-names>H.</given-names></name> <name><surname>Akira</surname> <given-names>M.</given-names></name> <name><surname>Noriyasu</surname> <given-names>S.</given-names></name> <name><surname>Jun</surname> <given-names>T.</given-names></name> <name><surname>John</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>99</volume> <fpage>13003</fpage>&#x2013;<lpage>13008</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.202477099</pub-id> <pub-id pub-id-type="pmid">12242343</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Guo</surname> <given-names>X. K.</given-names></name> <name><surname>Gao</surname> <given-names>L.</given-names></name> <name><surname>Huang</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Jia</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>MicroRNA-23 inhibits PRRSV replication by directly targeting PRRSV RNA and possibly by upregulating type I interferons.</article-title> <source><italic>Virology</italic></source> <volume>450&#x2013;451</volume> <fpage>182</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2013.12.020</pub-id> <pub-id pub-id-type="pmid">24503081</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhenzhen</surname> <given-names>C.</given-names></name> <name><surname>Cun</surname> <given-names>Z.</given-names></name> <name><surname>Yuehuan</surname> <given-names>L.</given-names></name> <name><surname>Yuehuan</surname> <given-names>L.</given-names></name> <name><surname>Weicheng</surname> <given-names>Y.</given-names></name> <name><surname>Jingwen</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Tembusu virus in ducks, china.</article-title> <source><italic>Emerg. Infect. Dis.</italic></source> <volume>17</volume> <fpage>1873</fpage>&#x2013;<lpage>1875</lpage>. <pub-id pub-id-type="doi">10.3201/eid1710.101890</pub-id> <pub-id pub-id-type="pmid">22000358</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Yan</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>miR-281, an abundant midgut-specific miRNA of the vector mosquito Aedes albopictus enhances dengue virus replication.</article-title> <source><italic>Parasit. Vect.</italic></source> <volume>7</volume> <fpage>488</fpage>&#x2013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1186/s13071-014-0488-4</pub-id> <pub-id pub-id-type="pmid">25331963</pub-id></citation></ref>
</ref-list>
</back>
</article>
